Japan Global Regulation

The questions brands preparing to export to Japan ask most often — answered by OTC experts.

A

The key question is where the effect is expected to arise.

  • Cosmetics

Products expected to have a general effect overall, such as cleansing or moisturizing the skin.

Japan operates a negative list of prohibited and restricted ingredients together with positive lists for certain permitted ingredients.

  • Quasi-drugs

Products that, beyond cosmetic function, claim efficacy through specific active ingredients.

Typical examples include whitening, acne prevention, UV-related efficacy, deodorant and hair growth.

Both active ingredients and additives are controlled within permitted ranges.

A

No. They may be sold as either cosmetics or quasi-drugs.

  • Sold as a cosmetic

Claims may focus on the physical blocking function of UV absorbers and scatterers.

  • Permitted wording:
  • Prevents sunburn
  • Prevents freckles and blemishes caused by sunburn
  • Sold as a quasi-drug

UV-filter ingredients themselves are classified as additives, so the application must be made together with a separate active ingredient.

In that case the total amount of UV absorbers used as additives must not exceed 10%.

  • Prevents rough skin caused by sun or snow exposure
  • Protects the skin

(Where a whitening active ingredient is included) Inhibits melanin production and prevents freckles and blemishes

A

SPF and PA testing is generally performed, but submission of the results is not mandatory for approval applications or notifications.

Separate test data may nevertheless be required depending on the sales strategy or customer requirements.

  • Representative test methods:
  • SPF: ISO 24444
  • PA (UVA): ISO 24442
  • Water resistance: ISO 18861
A

Whitening wording differs according to whether the product is a quasi-drug.

  • Quasi-drug

Active ingredients: arbutin, vitamin C derivatives, tranexamic acid, nicotinamide, kojic acid and others

Permitted wording: inhibits melanin production and prevents freckles and blemishes

  • Cosmetic

Permitted wording: prevents freckles and blemishes caused by sunlight — mainly in connection with UV-protection function

A

The permitted scope differs between quasi-drugs and cosmetics.

  • Quasi-drug
  • Active ingredients: retinol, niacinamide and others
  • Permitted wording: improves wrinkles
  • Cosmetic

Permitted wording: makes fine lines caused by dryness less noticeable. Using this wording may require evaluation testing in accordance with Japanese guidelines.

A

Yes. Naming systems can differ in particular between quasi-drugs and cosmetics.

  • Examples:

Quasi-drug: nicotinamide (whitening or additive), niacinamide (wrinkle improvement)

  • Cosmetic: niacinamide

When changing product type it is necessary to review the full ingredient list, approval documents and labeling wording together.

Note: this FAQ is general guidance for understanding the Japanese cosmetic and quasi-drug systems. Individual review is required for each product depending on its formulation, labeling, claims and sales format.

Can't find the regulation you're looking for? Our OTC experts answer directly — from the development stage to regulatory compliance.
Ask a Regulatory Question
아이콘
Clinical Research
Location
Inquiry